Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nanomedicine: current status and future prospects.

S Moein Moghimi1, A Christy Hunter, J Clifford Murray

  • 1Molecular Targeting and Polymer Toxicology Group, School of Pharmacy, University of Brighton, Brighton, UK.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|March 5, 2005
PubMed
Summary

Nanomedicine utilizes nanotechnology for targeted drug delivery and medical imaging. This approach rationally designs nanoscale vehicles to improve therapeutic efficacy and minimize side effects for various diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors.

Science advances·2025
Same author

Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts.

ACS nano·2024
Same author

Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic.

Advances in experimental medicine and biology·2024
Same author

Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions.

ACS nano·2024
Same author

Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin.

Molecular pharmaceutics·2024
Same author

Validation of dot blot immunoassay for measurement of complement opsonization of nanoparticles.

Journal of immunological methods·2024

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Pharmacology

Background:

  • Nanomedicine, as defined by the National Institutes of Health, applies nanotechnology to biological systems for treatment, diagnosis, monitoring, and control.
  • Rational drug delivery and targeting are central to nanomedicine research, focusing on specific cellular and receptor targets.

Purpose of the Study:

  • To highlight rational design and surface engineering of nanoscale vehicles for site-specific drug delivery and medical imaging.
  • To discuss potential pitfalls and side effects associated with nanoparticle applications.

Main Methods:

  • Identification of precise cellular and receptor targets (e.g., mononuclear phagocytes, dendritic cells, endothelial cells, cancer cells, tumor neovasculature).
  • Selection and design of appropriate nanocarriers for targeted administration.

Related Experiment Videos

  • Surface engineering of nanoscale vehicles for enhanced targeting and efficacy.

    • Main Results:

    • Nanotechnology approaches are expanding the market for existing drugs and creating profitable niches.
    • Rational design and surface engineering enable site-specific drug delivery and medical imaging.
    • Potential side effects and pitfalls of nanoparticle use are also considered.

    Conclusions:

    • Nanomedicine offers promising avenues for targeted therapies and diagnostics through rational design of nanocarriers.
    • Careful consideration of target identification and nanocarrier properties is crucial for maximizing benefits and minimizing risks.
    • Further research into nanoparticle design and safety is essential for clinical translation.